BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29038297)

  • 1. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.
    Masugi Y; Nishihara R; Hamada T; Song M; da Silva A; Kosumi K; Gu M; Shi Y; Li W; Liu L; Nevo D; Inamura K; Cao Y; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig SJ; Fuchs CS; Qian ZR; Nowak JA; Ogino S
    Cancer Immunol Res; 2017 Nov; 5(11):1046-1055. PubMed ID: 29038297
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S
    Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
    Masugi Y; Nishihara R; Yang J; Mima K; da Silva A; Shi Y; Inamura K; Cao Y; Song M; Nowak JA; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig S; Fuchs CS; Qian ZR; Ogino S
    Gut; 2017 Aug; 66(8):1463-1473. PubMed ID: 27196573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.
    Haruki K; Kosumi K; Hamada T; Twombly TS; Väyrynen JP; Kim SA; Masugi Y; Qian ZR; Mima K; Baba Y; da Silva A; Borowsky J; Arima K; Fujiyoshi K; Lau MC; Li P; Guo C; Chen Y; Song M; Nowak JA; Nishihara R; Yanaga K; Zhang X; Wu K; Bullman S; Garrett WS; Huttenhower C; Meyerhardt JA; Giannakis M; Chan AT; Fuchs CS; Ogino S
    J Pathol; 2020 Apr; 250(4):397-408. PubMed ID: 31880318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy.
    Huang KC; Chiang SF; Chen TW; Chen WT; Yang PC; Ke TW; Chao KSC
    Sci Rep; 2020 Dec; 10(1):22330. PubMed ID: 33339860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.
    Liu L; Nishihara R; Qian ZR; Tabung FK; Nevo D; Zhang X; Song M; Cao Y; Mima K; Masugi Y; Shi Y; da Silva A; Twombly T; Gu M; Li W; Hamada T; Kosumi K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Wu K; Wang M; Garrett WS; Chan AT; Fuchs CS; Giovannucci EL; Ogino S
    Gastroenterology; 2017 Dec; 153(6):1517-1530.e14. PubMed ID: 28865736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relationship between
    Ugai T; Shimizu T; Kawamura H; Ugai S; Takashima Y; Usui G; Väyrynen JP; Okadome K; Haruki K; Akimoto N; Masugi Y; da Silva A; Mima K; Zhang X; Chan AT; Wang M; Garrett WS; Freeman GJ; Meyerhardt JA; Nowak JA; Song M; Giannakis M; Ogino S
    Clin Transl Immunology; 2023; 12(8):e1453. PubMed ID: 37538192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
    J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.
    Ogino S; Nosho K; Irahara N; Meyerhardt JA; Baba Y; Shima K; Glickman JN; Ferrone CR; Mino-Kenudson M; Tanaka N; Dranoff G; Giovannucci EL; Fuchs CS
    Clin Cancer Res; 2009 Oct; 15(20):6412-20. PubMed ID: 19825961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction.
    Fujiyoshi K; Chen Y; Haruki K; Ugai T; Kishikawa J; Hamada T; Liu L; Arima K; Borowsky J; Väyrynen JP; Zhao M; Lau MC; Gu S; Shi S; Akimoto N; Twombly TS; Drew DA; Song M; Chan AT; Giovannucci EL; Meyerhardt JA; Fuchs CS; Nishihara R; Lennerz JK; Giannakis M; Nowak JA; Zhang X; Wu K; Ogino S
    JNCI Cancer Spectr; 2020 Aug; 4(5):pkaa040. PubMed ID: 32923934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer.
    Dou R; Nishihara R; Cao Y; Hamada T; Mima K; Masuda A; Masugi Y; Shi Y; Gu M; Li W; da Silva A; Nosho K; Zhang X; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Cancer Immunol Res; 2016 Nov; 4(11):927-935. PubMed ID: 27737877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
    Hamada T; Liu L; Nowak JA; Mima K; Cao Y; Ng K; Twombly TS; Song M; Jung S; Dou R; Masugi Y; Kosumi K; Shi Y; da Silva A; Gu M; Li W; Keum N; Wu K; Nosho K; Inamura K; Meyerhardt JA; Nevo D; Wang M; Giannakis M; Chan AT; Giovannucci EL; Fuchs CS; Nishihara R; Zhang X; Ogino S
    Eur J Cancer; 2018 Nov; 103():98-107. PubMed ID: 30219720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.
    Tanegashima T; Togashi Y; Azuma K; Kawahara A; Ideguchi K; Sugiyama D; Kinoshita F; Akiba J; Kashiwagi E; Takeuchi A; Irie T; Tatsugami K; Hoshino T; Eto M; Nishikawa H
    Clin Cancer Res; 2019 Aug; 25(15):4808-4819. PubMed ID: 31076547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA MIR21 and T Cells in Colorectal Cancer.
    Mima K; Nishihara R; Nowak JA; Kim SA; Song M; Inamura K; Sukawa Y; Masuda A; Yang J; Dou R; Nosho K; Baba H; Giovannucci EL; Bowden M; Loda M; Giannakis M; Bass AJ; Dranoff G; Freeman GJ; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Cancer Immunol Res; 2016 Jan; 4(1):33-40. PubMed ID: 26419959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
    Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.
    Howitt BE; Sun HH; Roemer MG; Kelley A; Chapuy B; Aviki E; Pak C; Connelly C; Gjini E; Shi Y; Lee L; Viswanathan A; Horowitz N; Neuberg D; Crum CP; Lindeman NL; Kuo F; Ligon AH; Freeman GJ; Hodi FS; Shipp MA; Rodig SJ
    JAMA Oncol; 2016 Apr; 2(4):518-22. PubMed ID: 26913631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
    Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of
    Ugai T; Zhao M; Shimizu T; Akimoto N; Shi S; Takashima Y; Zhong R; Lau MC; Haruki K; Arima K; Fujiyoshi K; Langworthy B; Masugi Y; da Silva A; Nosho K; Baba Y; Song M; Chan AT; Wang M; Meyerhardt JA; Giannakis M; Väyrynen JP; Nowak JA; Ogino S
    Oncoimmunology; 2021; 10(1):1956173. PubMed ID: 34377593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor
    Hamada T; Soong TR; Masugi Y; Kosumi K; Nowak JA; da Silva A; Mu XJ; Twombly TS; Koh H; Yang J; Song M; Liu L; Gu M; Shi Y; Nosho K; Morikawa T; Inamura K; Shukla SA; Wu CJ; Garraway LA; Zhang X; Wu K; Meyerhardt JA; Chan AT; Glickman JN; Rodig SJ; Freeman GJ; Fuchs CS; Nishihara R; Giannakis M; Ogino S
    Oncoimmunology; 2018; 7(7):e1442999. PubMed ID: 29900052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.